Global Glycobiology Market Expected to Reach XX Million by 2025

2018-03-09 17:14:41

According to a new report published by Reports Monitor titled, “Glycobiology Market by product, by application, and by end user: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the Glycobiology market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from 2017 to 2025. North America dominates the Glycobiology market, in  terms of value, and is expected to maintain this trend throughout the forecast period. 

Growing R&D expenditure and increasing funding for study of glycobiology, technological advancements in glycobiology instruments, and increased focus of pharmaceutical and biotechnological companies to provide upgraded drugs are some of the drivers to the growth of the market.

Get a Sample PDF Report @

Increasing popularity of personalized medicine in the treatment of genetic disorders and chronic diseases are some of the factors responsible for the market growth.
Stringent regulatory guideline and time consuming approval process restricts the entry of new players to the market which might hamper the growth of the market.

• In product segment enzyme is the fastest growing segment due to increased application of glycobiology in research and diagnostic.
• Drug discovery & development contribute largest revenue share in the market.
•  The academic and research institutes dominated the glycobiology market by contributing highest revenue.
• North America is expected to be dominating region in the glycobiology market. 

The major companies profiled in the report include Agilent Technologies, Inc., Waters Corporation, Merck KGaA, Bruker Corporation, Danaher Corporation, Shimadzu Corporation, New England Biolabs,ProZyme, Inc and Thermo Fisher Scientific. 

About Us:

We at Garner provide a comprehensive analysis by providing in-depth reports of the various market verticals. Our Mission is to provide a detailed analysis of the vast markets worldwide backed by rich data. Decision makers can now rely on our well-defined data gathering methods to get the correct and accurate market forecasting along with detailed analysis.

Contact Us:

Mr. Kevin Thomas
+1 513 549 5911 (US)
+44 203 318 2846 (UK)
Email: [email protected]

Related Press Releases